Managing Treatment for Patients with Relapsed/Refractory Lymphoma

Sonali M. Smith, MD, FASCO, The University of Chicago, Chicago, IL Recorded on January 25, 2021 How do we start the conversation? How do we discuss patient expectation and the likelihood of relapse? What role does the timing of relapse play? In this episode, Dr. Sonali Smith, the Elwood V. Jensen Professor of Medicine at The University of Chicago, discusses expectations for disease control and for relapse, the mechanisms of resistance, exciting advances in the treatment of relapsed/refractory lymphoma, including new treatments, and so much more. Tune in to this important talk today! Sonali Smith, MD, FASCO Elwood V. Jensen Professor of Medicine Chief, Section of Hematology/Oncology Co-Leader, Cancer Service Line Co-Director, Lymphoma Program The University of Chicago Chicago, IL This podcast episode is supported by Epizyme.